CombiGene

CombiGene's vision is to provide better life opportunities for patients affected by severe life-altering diseases through innovative gene therapies. CombiGene’s business concept is to develop effective gene therapies for serious diseases that currently lack appropriate treatment options. Research assets are acquired from an external network of researchers and further developed to clinical proof-of-concept. Candidate drugs targeting common diseases will be co-developed and commercialized through strategic partnerships, while CombiGene may drive the development and commercialization of drugs internally for limited patient populations.